Technical Analysis for HBIO - Harvard Bioscience, Inc.

Grade Last Price % Change Price Change
grade D 3.66 0.83% 0.03
HBIO closed up 0.83 percent on Tuesday, March 19, 2019, on 52 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Down
See historical HBIO trend table...

Date Alert Name Type % Chg
Mar 19 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Mar 19 Narrow Range Bar Range Contraction 0.00%
Mar 19 NR7 Range Contraction 0.00%
Mar 19 NR7-2 Range Contraction 0.00%
Mar 19 Oversold Stochastic Weakness 0.00%
Mar 18 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.83%
Mar 18 Narrow Range Bar Range Contraction 0.83%
Mar 18 NR7 Range Contraction 0.83%
Mar 18 Doji - Bullish? Reversal 0.83%
Mar 18 Down 3 Days in a Row Weakness 0.83%

Older signals for HBIO ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Harvard Bioscience, Inc., together with its subsidiaries, develops, manufactures, distributes, and markets specialized products, primarily apparatus and scientific instruments used to advance life science research and regenerative medicine. It operates through two segments, Life Science Research Tools and Regenerative Medicine Device. The company's products primarily target ADMET testing and molecular biology application areas. Its ADMET testing products include absorption diffusion chambers that measure the absorption of a drug into the bloodstream; well equilibrium dialysis plate for serum protein binding assays; organ testing systems; infusion pumps; behavioral products used in neuroscience, cardiology, psychological, and respiratory studies to evaluate the effects of situational stimuli, drugs, and nutritional infusions on motor and sensory, activity, and learning and test behavior; cell injection systems; ventilators; and electroporation products. The company's molecular biology products include molecular biology spectrophotometers, DNA/RNA/protein calculators, multi-well plate readers, liquid dispensers, and amino acid analysis and gel electrophoresis systems, as well as liquid handling consumables, such as pipettes, pipette tips, autoradiography films, gloves, thermal cycler accessories, and reagents. It also distributes devices, instruments, and consumables used in experiments involving cells, tissues, organs, and animals in the fields of proteomics, physiology, pharmacology, neuroscience, cell biology, molecular biology, and toxicology; and manufactures microdialysis products, synthetic scaffolds, bioreactors, and cell biology and electrophysiology products. The company sells its products to pharmaceutical and biotechnology companies, universities, and government laboratories through distributors, catalogs, and its field sales organization and Website worldwide. Harvard Bioscience, Inc. was founded in 1901 and is headquartered in Holliston, Massachusetts.
Chemistry Biotechnology Physical Sciences Natural Sciences Molecular Biology Dialysis Neuroscience Cell Biology Agilent Technologies Regenerative Medicine Proteomics Gel Electrophoresis
Is HBIO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.7
52 Week Low 2.75
Average Volume 103,561
200-Day Moving Average 4.4866
50-Day Moving Average 3.583
20-Day Moving Average 3.909
10-Day Moving Average 3.738
Average True Range 0.2232
ADX 20.38
+DI 15.6514
-DI 15.9777
Chandelier Exit (Long, 3 ATRs ) 3.7604
Chandelier Exit (Short, 3 ATRs ) 4.2596
Upper Bollinger Band 4.3117
Lower Bollinger Band 3.5063
Percent B (%b) 0.19
BandWidth 20.603735
MACD Line 0.0009
MACD Signal Line 0.0611
MACD Histogram -0.0603
Fundamentals Value
Market Cap 127.49 Million
Num Shares 34.8 Million
EPS -0.13
Price-to-Earnings (P/E) Ratio -28.15
Price-to-Sales 1.19
Price-to-Book 1.60
PEG Ratio 2.65
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.80
Resistance 3 (R3) 3.80 3.75 3.78
Resistance 2 (R2) 3.75 3.71 3.75 3.77
Resistance 1 (R1) 3.70 3.69 3.73 3.71 3.76
Pivot Point 3.65 3.65 3.66 3.65 3.65
Support 1 (S1) 3.61 3.62 3.63 3.61 3.56
Support 2 (S2) 3.56 3.59 3.56 3.55
Support 3 (S3) 3.51 3.56 3.54
Support 4 (S4) 3.52